Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus.
Antiviral Res. 2023 Jan;209:105474. doi: 10.1016/j.antiviral.2022.105474. Epub 2022 Nov 26.
Antiviral Res. 2023.
PMID: 36511318
Free PMC article.
Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.
Duty JA, Kraus T, Zhou H, Zhang Y, Shaabani N, Yildiz S, Du N, Singh A, Miorin L, Li D, Stegman K, Ophir S, Cao X, Atanasoff K, Lim R, Mena I, Bouvier NM, Kowdle S, Carreño JM, Rivero-Nava L, Raskin A, Moreno E, Johnson S, Rathnasinghe R, Pai CI, Kehrer T, Cabral EP, Jangra S, Healy L, Singh G, Warang P, Simon V, Sordillo EM, van Bakel H, Liu Y, Sun W, Kerwin L, Teijaro J, Schotsaert M, Krammer F, Bresson D, García-Sastre A, Fu Y, Lee B, Powers C, Moran T, Ji H, Tortorella D, Allen R.
Duty JA, et al.
Med. 2022 Oct 14;3(10):705-721.e11. doi: 10.1016/j.medj.2022.08.002. Epub 2022 Aug 8.
Med. 2022.
PMID: 36044897
Free PMC article.
Item in Clipboard
An in vitro experimental pipeline to characterize the epitope of a SARS-CoV-2 neutralizing antibody.
Atanasoff KE, Brambilla L, Adelsberg DC, Kowdle S, Stevens CS, Slamanig S, Hung C-T, Fu Y, Lim R, Tran L, Allen R, Sun W, Duty JA, Bajic G, Lee B, Tortorella D.
Atanasoff KE, et al.
mBio. 2024 Jan 16;15(1):e0247723. doi: 10.1128/mbio.02477-23. Epub 2023 Dec 6.
mBio. 2024.
PMID: 38054729
Free PMC article.
Item in Clipboard
The CD46 ectodomain participates in human cytomegalovirus infection of epithelial cells.
Parsons AJ, Stein KR, Atanasoff KE, Ophir SI, Casado JP, Tortorella D.
Parsons AJ, et al. Among authors: atanasoff ke.
J Gen Virol. 2023 Sep;104(9):001892. doi: 10.1099/jgv.0.001892.
J Gen Virol. 2023.
PMID: 37668349
Free PMC article.
Item in Clipboard
An in vitro experimental pipeline to characterize the binding specificity of SARS-CoV-2 neutralizing antibodies.
Atanasoff KE, Brambilla L, Adelsberg DC, Kowdle S, Stevens CS, Hung CT, Fu Y, Lim R, Tran L, Allen R, Andrew Duty J, Bajic G, Lee B, Tortorella D.
Atanasoff KE, et al.
bioRxiv [Preprint]. 2023 Apr 21:2023.04.20.537738. doi: 10.1101/2023.04.20.537738.
bioRxiv. 2023.
PMID: 37131698
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Cite
Cite